Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California.
52W High
$9.88
52W Low
$1.94
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.13
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.36
EV/Revenue (<3 favorable)
0.09
P/S (TTM) (<3 favorable)
0.64
P/B (<3 favorable)
1.86
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
1.28%
Institutions (25–75% balanced)
14.89%
Shares Outstanding
1,558,500
Float
1,390,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
12,794,900
Gross Profit (TTM)
12,363,000
EPS (TTM)
-1.25
Profit Margin (>10% good)
-0.42%
Operating Margin (TTM) (higher better)
-0.42%
ROE (TTM) (>15% strong)
-1.53%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.47
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—